ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is IDEAYA Biosciences, Inc. ?
1
With a growth in Net Profit of 46.84%, the company declared Outstanding results in Jun 25
- The company has declared positive results in Jan 70 after 9 consecutive negative quarters
- NET PROFIT(HY) Higher at USD -149.67 MM
- RAW MATERIAL COST(Y) Fallen by 0% (YoY)
- NET SALES(9M) Higher at USD 7 MM
2
Rising Promoter Confidence
- Promoters have increased their stake in the company by 1.3% over the previous quarter and currently hold 10.26% of the company
- Promoters increasing their stake is a sign of high confidence in the future of the business
3
Market Beating performance in long term as well as near term
- Along with generating 33.72% returns in the last 1 year, the stock has outperformed S&P 500 in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to IDEAYA Biosciences, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is IDEAYA Biosciences, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
IDEAYA Biosciences, Inc.
35.07%
-0.14
52.86%
S&P 500
13.22%
0.61
20.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
51.57%
EBIT Growth (5y)
-243.11%
EBIT to Interest (avg)
-136.29
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.68
Sales to Capital Employed (avg)
0.04
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.86
EV to EBIT
-3.36
EV to EBITDA
-3.40
EV to Capital Employed
3.65
EV to Sales
172.99
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-108.56%
ROE (Latest)
-29.98%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Bullish
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend8What is working for the Company
NET PROFIT(HY)
Higher at USD -149.67 MM
RAW MATERIAL COST(Y)
Fallen by 0% (YoY
NET SALES(9M)
Higher at USD 7 MM
DEBTORS TURNOVER RATIO(HY)
Highest at 14,000 times
-17What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -293.7 MM
ROCE(HY)
Lowest at -35.09%
PRE-TAX PROFIT(Q)
At USD -77.49 MM has Fallen at -46.84%
NET PROFIT(Q)
At USD -77.49 MM has Fallen at -46.84%
Here's what is working for IDEAYA Biosciences, Inc.
Net Sales
At USD 7 MM has Grown at 78.43%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (USD MM)
Debtors Turnover Ratio
Highest at 14,000 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Net Sales
Higher at USD 7 MM
than preceding 12 month period ended Jun 2025MOJO Watch
In the nine month period the company has already crossed sales of the previous twelve months
Net Sales (USD MM)
Raw Material Cost
Fallen by 0% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at USD 1.23 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (USD MM)
Here's what is not working for IDEAYA Biosciences, Inc.
Operating Cash Flow
Lowest at USD -293.7 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Pre-Tax Profit
At USD -77.49 MM has Fallen at -46.84%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (USD MM)
Net Profit
At USD -77.49 MM has Fallen at -46.84%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (USD MM)
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
